Stop overselling GM on yield, warns plant breeding researcher
By Claire Robinson,
GMWatch
| 09. 26. 2023
Photo by Shuken Nakamura on Unsplash
A young researcher studying plant breeding for her PhD at Cornell University has just published a paper warning GMO promoters not to make overhyped claims about supposed yield gains from GM crops. Merritt Khaipho-Burch is the first author on the new publication, called “Genetic modification can improve crop yields — but stop overselling it”.
Khaipho-Burch initially made her case on Twitter last year, comprehensively debunking papers published in Science Magazine reporting massive yield gains from genetic engineering in rice and soybean plants. The click-bait claims made by Science about these papers were lapped up uncritically by the mainstream media, leading Khaipho-Burch to condemn both papers as “misleading” and former Science Magazine reporter Michael Balter to accuse the journal of being “way too credulous” in certain topic areas of science, such as GMO research.
Now Khaipho-Burch and her co-authors have taken the discussion to a higher level, in the form of a peer-reviewed paper in the world’s leading multidisciplinary science journal, Nature, which drives home many points that GMWatch has been making for years...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...